Back to search
FDAFDA · Food and drugs·Recall number D-1248-2019

Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05

Published April 17, 2019 · Recall initiated: March 28, 2019

Summary

FDA records drug Class I recall D-1248-2019, published April 17, 2019 and initiated March 28, 2019. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 88600 vials; Lot: Lot #: CLC180117, Exp. June 2021. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: One vial was found to contain a hair.

What to do

Voluntary: Firm initiated · Letter

Get an email if MARBETA L KIT has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MARBETA L KIT
Manufacturer
Aurobindo Pharma USA Inc.
Distributor
Product is being held at a distributor site in Mexico, Asheboro, NC, Charlotte, NC and Santa Teresa, NM and not further distributed in the U.S. Market.
Lot
Lot #: CLC180117, Exp. June 2021
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05 recalled?

Yes. FDA published recall D-1248-2019 on April 17, 2019. Reported hazard: Presence of Particulate Matter: One vial was found to contain a hair.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MARBETA L KIT.